AIN HOLDINGS INC. Summary of Financial Statements for the Second Quarter of Fiscal Year Ending April 2022
[Japan GAAP] (Consolidated)
December 3, 2021
Name of listed company: | AIN HOLDINGS INC. | |
Exchange listed on: | First Section of Tokyo Stock Exchange and Sapporo Securities Exchange | |
Code number: | 9627 | URL: https://www.ainj.co.jp/ |
Representative: | Kiichi Otani, President and Representative Director | |
Inquiries: | Toshihide Mizushima, Representative Senior Managing Director | |
TEL: +81-11-814-1000 |
Date of filing quarterly securities report: | December 15, 2021 |
Start of dividend payment: | - |
Supplementary documents for quarterly results: | Yes (Supplementary materials for the quarterly results are disclosed on the |
Company's website appropriately as the financial statements.) | |
Quarterly results briefing: | Yes (for institutional investors and analysts) |
(Amounts are rounded down to the nearest million yen.) |
1. Consolidated results for the second quarter of fiscal year ending April 30, 2022 (May 1, 2021 to October 31, 2021)
- Consolidated operating results
(Percentage figures show year-on-yearchanges.) | ||||||||||||||||||||||||||
Net sales | Operating profit | Ordinary profit | Profit attributable to | |||||||||||||||||||||||
owners of parent | ||||||||||||||||||||||||||
Million yen | % | Million yen | % | Million yen | % | Million yen | % | |||||||||||||||||||
Six months ended October 31, 2021 | 152,972 | 5.2 | 5,776 | 47.1 | 6,127 | 35.6 | 3,338 | 26.9 | ||||||||||||||||||
Six months ended October 31, 2020 | 145,352 | (0.3) | 3,927 | (53.0) | 4,517 | (48.4) | 2,630 | (43.1) | ||||||||||||||||||
(Note) Comprehensive income: | Six months | ended October 31, 2021: | ¥3,311 million | (+24.3%) | ||||||||||||||||||||||
Six months ended October 31, 2020: | ¥2,664 million | (-42.2%) | ||||||||||||||||||||||||
Earnings | Diluted earnings | |||||||||||||||||||||||||
per share | per share | |||||||||||||||||||||||||
Yen | Yen | |||||||||||||||||||||||||
Six months ended October 31, 2021 | 94.68 | - | ||||||||||||||||||||||||
Six months ended October 31, 2020 | 74.24 | - | ||||||||||||||||||||||||
(2) Consolidated financial position | ||||||||||||||||||||||||||
Total assets | Net assets | Shareholders' equity ratio | ||||||||||||||||||||||||
Million yen | Million yen | % | ||||||||||||||||||||||||
As of October 31, 2021 | 210,442 | 115,810 | 55.0 | |||||||||||||||||||||||
As of April 30, 2021 | 203,662 | 115,837 | 56.8 | |||||||||||||||||||||||
(Reference) Shareholders' equity: As of October 31, 2021: ¥115,741 million | As of April 30, 2021: ¥115,758 million | |||||||||||||||||||||||||
2. Dividends | ||||||||||||||||||||||||||
Dividend per share | ||||||||||||||||||||||||||
End of first | End of second | End of third | End of year | Full year | ||||||||||||||||||||||
quarter | quarter | quarter | ||||||||||||||||||||||||
Yen | Yen | Yen | Yen | Yen | ||||||||||||||||||||||
Year ended April 30, 2021 | - | 0.00 | - | 55.00 | 55.00 | |||||||||||||||||||||
Year ending April 30, 2022 | - | 0.00 | ||||||||||||||||||||||||
Year ending April 30, 2022 | - | 55.00 | 55.00 | |||||||||||||||||||||||
(forecast) | ||||||||||||||||||||||||||
(Note) Revision to the most recently announced dividend forecasts: No |
3. Consolidated financial forecasts for the fiscal year ending April 30, 2022 (May 1, 2021 to April 30, 2022)
(Percentage figures show year-on-year changes.)
Net sales | Operating profit | Ordinary profit | Profit attributable to | Earnings | ||||||
owners of parent | per share | |||||||||
Million yen | % | Million yen | % | Million yen | % | Million yen | % | Yen | ||
Full year | 315,000 | 6.0 | 15,000 | 37.2 | 15,500 | 22.5 | 8,300 | 23.9 | 234.28 |
(Note) Revision to the most recently announced consolidated financial forecasts: No
*Notes
(1) Major changes in subsidiaries during the period (changes in specified subsidiaries resulting from changes in scope of
consolidation): No | |
Newly consolidated: - | Excluded: - |
- Application of specified accounting methods for the preparation of quarterly consolidated financial statements: Yes
(Note) For detail, please refer to "2. Quarterly consolidated financial statements and major notes (4) Notes on quarterly consolidated financial statements" on page 10 of the Attachment. - Changes in accounting principles, changes in accounting estimates, and restatement of revisions
1) | Changes in accounting principles as a result of revisions to accounting standards, etc.: | Yes |
2) | Changes in accounting principles other than 1): | No |
3) | Changes in accounting estimates: | No |
4) | Restatement of revisions: | No |
(4) Number of outstanding shares (common stock) | ||||||
1) | Number of outstanding | |||||
shares (including treasury | As of October 31, 2021 | 35,428,212 | shares As of April 30, 2021 | 35,428,212 | shares | |
stock): | ||||||
2) | Number of shares held in | As of October 31, 2021 | 200,911 | shares As of April 30, 2021 | 891 | shares |
treasury: | ||||||
3) | Average number of | Six months ended | Six months ended | |||
shares outstanding: | October 31, 2021 | 35,260,638 | shares October 31, 2020 | 35,427,442 | shares |
*This Summary of Financial Statements is outside the scope of quarterly review procedures.
*Statement regarding the proper use of financial forecasts and other special remarks (Caution concerning forward-looking statements)
The above forecasts are calculated based on the information available as of the publication date of this material, and actual financial results may vary due to change in future economic conditions and others.
AIN HOLDINGS INC. (9627) Summary of Financial Statements for the Second Quarter of the Fiscal Year Ending April 30, 2022
Contents of the Attachment | ||
Forecast of consolidated financial results and other forward-looking information ........................................................ | ||
2. Quarterly consolidated financial statements and major notes........................................................................................... | 4 | |
(1) | Quarterly consolidated balance sheet.......................................................................................................................... | 4 |
(2) | Quarterly consolidated statements of income and comprehensive income ................................................................. | 6 |
Quarterly consolidated statements of income................................................................................................................. | 6 | |
Quarterly consolidated statements of comprehensive income ....................................................................................... | 7 | |
(3) | Quarterly consolidated statements of cash flows......................................................................................................... | 8 |
(4) | Notes on quarterly consolidated financial statements................................................................................................ | 10 |
(Notes on the premise of a going concern)................................................................................................................... | 10 | |
(Notes on significant changes in the amount of shareholders' equity).......................................................................... | 10 | |
(Application of specified accounting methods for the preparation of quarterly consolidated financial statements)....... | 10 | |
(Changes in accounting policies).................................................................................................................................. | 10 | |
(Segment information, etc.) ........................................................................................................................................... | 11 |
1
AIN HOLDINGS INC. (9627) Summary of Financial Statements for the Second Quarter of the Fiscal Year Ending April 30, 2022
1. Qualitative information on consolidated results for the period under review
(1) Consolidated operating results
During the first six months of the current fiscal year (May 1, 2021 to October 31, 2021), the Japanese economy continued to face challenging conditions due to the COVID-19 outbreak. Despite signs of a pickup in the economy after the state of emergency and quasi-emergency measures were lifted throughout Japan at the end of September, the outlook remains uncertain.
In this economic environment, the Group put priority on ensuring the safety of patients, customers and employees and made concerted efforts to ensure the continued provision of healthcare and retail services, including vaccinating employees against COVID-19 through a workplace vaccination program and taking rigorous steps to prevent infection in pharmacies and stores. Working with local governments, the Japan Pharmaceutical Association and medical institutions, the Group also dispatched many pharmacists to support the safe and rapid rollout of COVID-19 vaccines in local communities.
In addition, in May 2021, we set fiscal 2026 targets for important issues that should be addressed by the Group (materiality) and started taking concrete steps towards the targets, including formulating a human rights policy and making preparations to disclose information in accordance with the recommendations of the Task Force on Climate-related Financial Disclosures (TCFD). Going forward, we will implement various initiatives to realize sustainability management that supports the Group's continued growth and creates social, environmental and economic value.
In the first six months of the fiscal year, net sales increased 5.2% year on year to ¥152,972 million, operating profit increased 47.1% to ¥5,776 million, ordinary profit increased 35.6% to ¥6,127 million, and profit attributable to owners of parent increased 26.9% to ¥3,338 million.
Financial results by business segment are as follows.
(Dispensing pharmacy business)
The Group is working to leverage the primary care capabilities of its pharmacists and dispensing pharmacies to help patients access medical services in their local community with peace of mind. Specifically, the Group is reinforcing pharmaceutical management and guidance and home-based healthcare, backed by integrated and continuous monitoring of patient medication data through cooperation with local medical service providers and the use of patient medication notebooks and other means.
In addition, as part of revisions to the Pharmaceuticals and Medical Devices Act that came into effect from August 2021, dispensing pharmacies can now gain certification as community coordination pharmacies or specialist medical institution coordination pharmacies, depending on their functions. Going forward, the Group will further reinforce home-based healthcare services, increase coordination with various medical professionals and enhance specialist pharmacist training in order to contribute to local healthcare provision as a company that meets community pharmacy needs.
In business development, the Group is targeting further business expansion through a strategy of actively opening large pharmacies and using M&A deals that emphasize investment returns, while also improving pharmacy operating efficiency.
As a result, for the first six months of the fiscal year, the dispensing pharmacy business reported sales of ¥136,905 million, up 6.9% year on year, and segment profit of ¥10,491 million, up 25.3% due to recovery of prescription volume of existing dispensing pharmacies and steady growth of dispensing pharmacies opened last fiscal year.
During the first six months of the fiscal year, the Group opened a total of 33 dispensing pharmacies, including those acquired through M&A deals, closed four dispensing pharmacies and sold three, resulting in a total of 1,091.
(Cosmetic and drug store business)
The cosmetic and drug store business continued to face a challenging market environment due to the impact of the COVID-19 pandemic.
The Group continued to create appealing retail displays by strengthening product lineups and worked to improve convenience and service levels for customers using the official AINZ & TULPE WEBSTORE e-commerce site.
Targeting post-pandemic opportunities, the Group also pushed ahead with store openings in prime locations that are expected to attract customers.
As a result, for the first six months of the fiscal year, the cosmetic and drug store business reported an increase in sales of 4.6% year on year to ¥9,816 million, and segment loss was ¥1,125 million compared with the loss of ¥1,014 million a year earlier.
During the same period, the Group opened four AINZ & TULPE cosmetic and drug stores and closed one store, resulting in a total of 72 cosmetic and drug stores at the end of the second quarter.
(Other businesses)
Net sales from other businesses decreased 21.2% year on year to ¥6,297 million and segment loss was ¥121 million compared with the loss of ¥435 million a year earlier.
The Company has applied the "Accounting Standard for Revenue Recognition" (ASBJ Statement No. 29, March 31, 2020),
2
AIN HOLDINGS INC. (9627) Summary of Financial Statements for the Second Quarter of the Fiscal Year Ending April 30, 2022
etc. from the beginning of the first quarter. For more details, please refer to "2. Quarterly consolidated financial statements and major notes, (4) Notes on quarterly consolidated financial statements, (Changes in accounting policies) and (Segment information, etc.).
(2) Consolidated financial position
The balance of total assets at the end of the second quarter increased by ¥6,779 million from the end of the previous fiscal year to ¥210,442 million. That mainly reflected a decline in notes and accounts receivable, outweighed by increases for cash on hand and in banks and for merchandise.
The balance of liabilities increased ¥6,806 million to ¥94,632 million.
The balance of short- term and long-term borrowings decreased by ¥2,054 million to ¥9,912 million.
Total net assets decreased by ¥26 million to ¥115,810 million and the shareholders' equity ratio decreased 1.8 percentage points to 55.0%.
(Cash flows)
In the first six months of the fiscal year, cash and cash equivalents ("cash") increased by ¥3,422 million from the previous fiscal year end to ¥58,432 million.
Cash flows from each activity and their relevant factors are as follows.
During the first six months of the fiscal year, net cash provided by operating activities was ¥17,314 million, compared with ¥6,441 million provided in the same period a year earlier. The main cash inflows were profit before income taxes of ¥6,064 million, depreciation of ¥2,117 million and amortization of goodwill of ¥2,055 million. The main cash outflow was income taxes paid of ¥1,907 million.
Net cash used in investing activities amounted to ¥8,261 million, compared with ¥3,759 million used in the same period a year earlier. The main use of cash was ¥3,590 million for purchases of property, plant and equipment and intangible assets.
Net cash used in financing activities totaled ¥5,630 million, compared with cash provided of ¥5,702 million in the same period a year earlier. The main uses of cash were a net repayment of ¥2,093 million from short-term and long-term borrowings repayment and proceeds, ¥1,948 million for cash dividends paid and ¥1,400 million for the purchase of treasury shares.
(3) Forecast of consolidated financial results and other forward-looking information
There are no changes to the Group's consolidated financial forecasts for the first six months or the fiscal year ending April 30, 2022, which were released on June 4, 2021.
3
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
AIN Holdings Inc. published this content on 03 December 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 December 2021 07:01:05 UTC.
